Khorshidi Mohammad, Roshan Payam, Bayat Nooshin, Mahdavi Mohammad Reza, Najmabadi Hossein
Kariminejad-Najmabadi Pathology & Genetics Center, 2 Medical Building, 4th Street, Hassan Seyf Street, Shahrak Gharb, Tehran, PO Box: 14665/154, Iran.
J Med Case Rep. 2012 Feb 6;6:47. doi: 10.1186/1752-1947-6-47.
Hemoglobin Q-Iran (α75Asp→His) is an important member of the hemoglobin Q family, molecularly characterized by the replacement of aspartic acid by histidine. The first report of hemoglobin Q-Iran and the nomenclature of this hemoglobinopathy dates back to 1970. Iran is known as a country with a high prevalence of α- and β-thalassemia and different types of hemoglobinopathy. Many of these variants are yet to be identified as the practice of molecular laboratory techniques is limited in this part of the world. Applying such molecular methods, we report the first hemoglobin Q-Iran cases in Northern Iran.
An unusual band was detected in an isoelectric focusing test and cellulose acetate electrophoresis of a sample from a 22-year-old Iranian man from Mazandaran Province. Capillary zone electrophoresis analysis identified this band as hemoglobin Q. A similar band was also detected in his mother's electrophoresis (38 years, Iranian ethnicity). The cases underwent molecular investigation and the presence of a hemoglobin Q-Iran mutation was confirmed by the amplification refractory mutation system polymerase chain reaction method. Direct conventional sequencing revealed a single guanine to cytosine missense mutation (c.226G > C; GAC >CAC) at codon 75 in the α-globin gene in both cases.
The wide spectrum and high frequency of nondeletional α-globin mutations in Mazandaran Province is remarkable and seem to differ considerably from what has been found in Mediterranean populations. This short communication reports the first cases of patients with hemoglobin Q found in that region.
血红蛋白Q-伊朗型(α75天冬氨酸→组氨酸)是血红蛋白Q家族的重要成员,其分子特征是天冬氨酸被组氨酸取代。血红蛋白Q-伊朗型的首次报道及这种血红蛋白病的命名可追溯到1970年。伊朗是一个α和β地中海贫血以及不同类型血红蛋白病高发的国家。由于该地区分子实验室技术的应用有限,许多这些变异尚未被鉴定出来。应用此类分子方法,我们报道了伊朗北部首例血红蛋白Q-伊朗型病例。
在对一名来自马赞德兰省的22岁伊朗男子的样本进行等电聚焦试验和醋酸纤维素电泳时,检测到一条异常条带。毛细管区带电泳分析确定这条带为血红蛋白Q。在他母亲(38岁,伊朗族裔)的电泳中也检测到了类似条带。对这些病例进行了分子研究,并通过扩增阻滞突变系统聚合酶链反应方法确认了血红蛋白Q-伊朗型突变的存在。直接常规测序显示,两例病例的α珠蛋白基因第75密码子均存在单个鸟嘌呤到胞嘧啶的错义突变(c.226G > C;GAC > CAC)。
马赞德兰省非缺失型α珠蛋白突变的广泛谱系和高频率值得关注,且似乎与在地中海人群中发现的情况有很大差异。本简短通讯报道了该地区首例血红蛋白Q患者病例。